Search results for " Infectious diseases"

showing 10 items of 138 documents

Visceral leishmaniasis, hypertriglyceridemia and secondary hemophagocytic lymphohistiocytosis

2016

cytokines, an upregulation of adhesion molecules and MHC I and II molecules on mono/macrophages, and an expansion of inflammatory monocytes. This exaggerated inflammatory response is responsible for necrosis and organ failure and results in uncontrolled proliferation and phagocytic activity of histiocytes [2]. Hypertriglyceridemia (fasting, greater than or equal to 265 mg/100 ml) is one of the current diagnostic criteria for HLH [2]. Several studies link hypertriglyceridemia to inhibition of lipoprotein lipase (LPL) by tumor necrosis factor-α (TNF-α), and TNF-α is a powerful autocrine and paracrine regulator of adipose tissue [3]. Indeed, many different sources of intense and prolonged T-ly…

Microbiology (medical); Infectious Diseases0301 basic medicineMicrobiology (medical)Secondary Hemophagocytic LymphohistiocytosisNecrosisSettore MED/17 - Malattie Infettive030106 microbiologyAdipose tissueTriglycerideSeverityLymphohistiocytosis Hemophagocytic03 medical and health sciences0302 clinical medicinemedicineHumansMacrophage030212 general & internal medicineVisceral leishmaniasisHypertriglyceridemiaLipoprotein lipasebusiness.industryAnemia; Severity; Triglyceride; Visceral leishmaniasisHypertriglyceridemiaAnemiaGeneral Medicinemedicine.diseaseInfectious DiseasesVisceral leishmaniasisImmunologyLeishmaniasis VisceralTumor necrosis factor alphamedicine.symptombusinessInfection
researchProduct

Die Lepra in Riga, ihre Ausbreitung und Bekämpfung: Vortrag, gehalten am 22. April 1911 in der Gesellschaft für kommunale Sozialpolitik in Riga

1911

"Als Manuskript gedruckt für die Mitglieder der Gesellschaft für kommunale Sozialpolitik in Riga."

Mycobacterial diseasesLepraLepra - izplatība un novēršana (Rīga)LeprosyMikobakteriālās slimības:MEDICINE::Microbiology immunology infectious diseases::Infectious diseases [Research Subject Categories]SpitālībaMikobaktēriju infekcijas
researchProduct

Advances in pediatrics in 2017: current practices and challenges in allergy, endocrinology, gastroenterology, genetics, immunology, infectious diseas…

2018

Abstract This review provides an overview of a remarkable number of significant studies in pediatrics that have been published over the past year in the Italian Journal of Pediatrics. We have selected information from papers presented in the Journal that deal with allergy, endocrinology, gastroenterology, genetics, immunology, infectious diseases, neonatology, nephrology, neurology, pulmonology. The relevant epidemiologic findings, and developments in prevention, diagnosis and treatment of the last year have been discussed and placed in context. We think that advances achieved in 2017 will help readers to make the future of patients better.

NephrologyPediatricsAllergyNeurologyAllergyPulmonologyNeurology PediatricsNeurology PediatricsReviewPediatricsGastroenterologyNeurology&nbsp0302 clinical medicineEndocrinologyNeurology PediatricPediatricGeneticsInfectious diseaselcsh:RJ1-570GastroenterologyPerinatology and Child HealthNeurology pediatricsPulmonologyNephrologyAllergy; Endocrinology; Gastroenterology; Genetics; Immunology; Infectious diseases; Neonatology; Nephrology; Neurology Pediatrics; PulmonologyInfectious diseasesHumanmedicine.medical_specialtyGenetics MedicalImmunologyContext (language use)03 medical and health sciencesGeneticAllergy and ImmunologyMedical030225 pediatricsInternal medicineInternal MedicinemedicineGeneticsHumansNeonatologyMaternal and child healthbusiness.industrylcsh:Pediatricsmedicine.diseaseNeurology PediatricsAllergy; Endocrinology; Gastroenterology; Genetics; Immunology; Infectious diseases; Neonatology; Nephrology; Neurology Pediatrics; Pulmonology; Humans; Allergy and Immunology; Genetics Medical; Internal Medicine; Pediatrics; Pediatrics Perinatology and Child HealthAllergy; Endocrinology; Gastroenterology; Genetics; Immunology; Infectious diseases; Neonatology; Nephrology; Neurology Pediatrics; PulmonologyEndocrinologyPediatrics Perinatology and Child HealthImmunologyNeonatologybusiness030217 neurology & neurosurgery
researchProduct

A return to humane medicine: Osler's legacy.

2017

Sir William Osler is celebrated today not only for his contributions to the advancement of medical education, but also for the humanism he brought to the practice of medicine. He was a doctor whose bedside skills and manners were emulated, and can legitimately be called an infectious diseases specialist. Nonetheless, he was also a humanist in the broader sense of the term, a student of human affairs and human nature, who emphasised compassion for the individual. To what extent, if any, are today's challenges influenced by departures from the paradigms created by Osler? In this paper we sought to ascertain whether such a tradition is still relevant to current practice and may foster a new pe…

OntarioInfectious Disease MedicinePhysician-Patient RelationsEducation MedicalHumanities Formazione medica Relazione medico-paziente Osler Empatia Medicina Interna Malattie infettiveAttitude of Health PersonnelHistory 19th CenturyHistory 20th CenturySettore MED/43 - MEDICINA LEGALEHumane Medicine Humanities Medical Education Patient-physician relationship Osler Empathy Internal Medicine Infectious diseasesUnited StatesSettore MED/02 - STORIA DELLA MEDICINAPhysiciansHumanismInternal MedicineOsler's legacyHumansHistory of MedicinePractice Patterns Physicians'Medicina umanaMedical Humanities
researchProduct

Comment on “Worldwide Distribution of PK Deficiency: the Defect Seems Mainly Concentrated in West African Countries and the United States.”

2021

PKlcsh:RC633-647.5business.industry10031 Clinic for Angiology2720 HematologyPK DEFICIENCYDistribution (economics)610 Medicine & healthPK deficiency2725 Infectious Diseaseslcsh:Diseases of the blood and blood-forming organsHematologyUnited StatesWest African CountriesWest africanInfectious Diseases10032 Clinic for Oncology and HematologyDeficiencyMedicinebusinessSocioeconomicsLetter to the EditorMediterranean Journal of Hematology and Infectious Diseases
researchProduct

Strategies for Disease Prevention and Health Promotion in Urban Areas: The Erice 50 Charter

2017

The Erice 50 Charter titled "Strategies for Diseases Prevention and Health Promotion in Urban Areas" was unanimously approved at the conclusion of the 50th Residential Course "Urban Health. Instruments for promoting health and for assessing hygienic and sanitary conditions in urban areas", held from 29th March to 2nd April 2017 in Erice, at the "Ettore Majorana" Foundation and Centre for Scientific Culture and promoted by the International School of Epidemiology and Preventive Medicine "G. D'Alessandro" and the Study Group "Building Hygiene" of the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI). At the conclusion of the intense learning experience during the Course…

Planning and Designing StrategiesUrban HealthHealth PromotionUrban Health Public Health Built Environment Planning and Designing Strategies Health PromotionPrimary PreventionItalyPlanning and Designing Strategiebuilt environment; health promotion; planning and designing strategies; public health; urban health; public health environmental and occupational health; infectious diseasesHumansUrban Health; Public Health; Built Environment; Planning and Designing Strategies; Health promotionHealth promotionPublic HealthBuilt EnvironmentBuilt Environment; Health Promotion; Planning and Designing Strategies; Public Health; Urban Health; Health Promotion; Humans; Italy; Primary Prevention; Urban Health
researchProduct

Definition of criteria and indicators for the prevention of Healthcare-Associated Infections (HAIs) in hospitals for the purposes of Italian institut…

2017

Background. Healthcare-associated infections (HAIs) are an important issue in terms of quality of care. HAIs impact patient safety by contributing to higher rates of preventable mortality and prolonged hospita- lizations. In Italy, analysis of the currently available accreditation systems shows a substantial heteroge- neity of approaches for the prevention and surveillance of HAIs in hospitals. The aim of the present study is to develop and propose the use of a synthetic assessment tool that could be implemented homogenously throughout the nation. Methods. An analysis of nine international and of the 21 Italian regional accreditation systems was conducted in order to identify requirements a…

Process Assessment (Health Care)Cross InfectionProcess Assessment Health CareEnvironmental and Occupational HealthOutcome indicatorsProcess AssessmentHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoring; Public Health Environmental and Occupational Health; Infectious DiseasesSettore MED/42 - Igiene Generale E ApplicataHospitalsAccreditationHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoring; Cross Infection; Hospitals; Humans; Italy; Accreditation; Process Assessment (Health Care)Health CareHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoringInstitutional accreditationPatient safetyHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoring; Cross Infection; Hospitals; Humans; Italy; Accreditation; Process Assessment Health CareInfectious DiseasesHealthcare-Associated Infections (HAIs) Patient safety Institutional accreditation Performance monitoring Outcome indicatorsItalySettore MED/33 - Malattie Apparato LocomotoreHumansOutcome indicatorPublic HealthPerformance monitoringHealthcare-Associated Infections (HAIs)
researchProduct

New active drugs against liver stages of Plasmodium predicted by molecular topology.

2008

ABSTRACT We conducted a quantitative structure-activity relationship (QSAR) study based on a database of 127 compounds previously tested against the liver stage of Plasmodium yoelii in order to develop a model capable of predicting the in vitro antimalarial activities of new compounds. Topological indices were used as structural descriptors, and their relation to antimalarial activity was determined by using linear discriminant analysis. A topological model consisting of two discriminant functions was created. The first function discriminated between active and inactive compounds, and the second identified the most active among the active compounds. The model was then applied sequentially t…

Quantitative structure–activity relationshipStereochemistryAntiparasiticmedicine.drug_classModels BiologicalAuto-immunity transplantation and immunotherapy [N4i 4]AntimalarialsMiceStructure-Activity RelationshipParasitic Sensitivity Testsparasitic diseasesmedicineAnimalsHumansStructure–activity relationshipPharmacology (medical)PharmacologybiologyPoverty-related infectious diseases [N4i 3]Plasmodium falciparumPlasmodium yoeliibiology.organism_classificationIn vitroInfectious Diseasesmedicine.anatomical_structureLiverBiochemistrySusceptibilityHepatocyteHepatocytesMicrobial pathogenesis and host defense [UMCN 4.1]Infection and autoimmunity [NCMLS 1]Plasmodium yoeliiFunction (biology)Immunity infection and tissue repair [NCMLS 1]
researchProduct

Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection.

2016

The treatment of HCV infection has seen significant progress, particularly since the approval of new direct-acting antiviral drugs. However these clinical achievements have been made despite an incomplete understanding of HCV replication and within-host evolution, especially compared with HIV-1. Here, we undertake a comprehensive analysis of HCV within-host evolution during chronic infection by investigating over 4000 viral sequences sampled longitudinally from 15 HCV-infected patients. We compare our HCV results to those from a well-studied HIV-1 cohort, revealing key differences in the evolutionary behaviour of these two chronic-infecting pathogens. Notably, we find an exceptional level o…

RNA viruses0301 basic medicineMaleHepacivirusHIV InfectionsHepacivirusPathology and Laboratory Medicinemedicine.disease_causeVirus ReplicationHepatitis0302 clinical medicineImmunodeficiency VirusesMedicine and Health Sciences2.2 Factors relating to the physical environmentChronicAetiologylcsh:QH301-705.5Data Managementeducation.field_of_studybiologyHepatitis C virusLiver Diseasevirus diseasesHepatitis C3. Good healthPhylogeneticsInfectious DiseasesMedical MicrobiologyViral PathogensViral evolutionVirusesEvolutionary RateHIV/AIDS030211 gastroenterology & hepatologyFemalePathogensInfectionResearch Articlelcsh:Immunologic diseases. AllergyComputer and Information SciencesEvolutionary ProcessesEvolutionHepatitis C virusPopulationChronic Liver Disease and CirrhosisImmunologyMicrobiologyViral EvolutionVirusEvolution Molecular03 medical and health sciencesHepatitis - CVirologyRetrovirusesGeneticsmedicineHumansEvolutionary SystematicsEvolutionary dynamicseducationMicrobial PathogensMolecular BiologyTaxonomyEvolutionary BiologyFlavivirusesPopulation BiologyLentivirusOrganismsBiology and Life SciencesHIVMolecularHepatitis C Chronicbiology.organism_classificationVirologyHepatitis virusesOrganismal EvolutionViral ReplicationChronic infection030104 developmental biologyEmerging Infectious Diseaseslcsh:Biology (General)Viral replicationMicrobial EvolutionImmunologyHIV-1Parasitologylcsh:RC581-607Digestive DiseasesPopulation GeneticsFollow-Up Studies
researchProduct

Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors.

2016

Aim. We conducted a cost-effectiveness analysis of seven hepatitis C virus (HCV) testing strategies in blood donors. Methods. Three of the seven strategies were based on HCV diagnosis and reporting guidelines in Mexico and four were from previous and current recommendations outlined by the CDC. The strategies that were evaluated determine antibody levels according to the signal-to-cut-off (S/CO) ratio and use reflex Immunoblot (IMB) or HCV RNA tests to confirm true positive (TP) cases of chronic HCV infection. Costs were calculated from the perspective of the Mexican Institute of Social Security (IMSS). A decision tree model was developed to estimate the expected number of true positive cas…

RNA virusesDecision AnalysisPhysiologyEconomicsCost-Benefit AnalysisSocial Scienceslcsh:MedicineBlood DonorsHepacivirusmedicine.disease_causeBiochemistryHepatitis0302 clinical medicineImmune Physiology030212 general & internal medicineChroniclcsh:SciencePathology and laboratory medicinehealth care economics and organizationsMultidisciplinaryImmune System ProteinsCost–benefit analysisHepatitis C virusLiver DiseaseCost-effectiveness analysisMedical microbiologyHepatitis CHCV AntibodyInfectious DiseasesVirusesEngineering and TechnologyBlood Banks030211 gastroenterology & hepatologyPathogensInfectionManagement EngineeringResearch Articlemedicine.medical_specialtyGeneral Science & TechnologyHepatitis C virusImmunologyCost-Effectiveness AnalysisImmunoblottingChronic Liver Disease and CirrhosisMolecular Probe TechniquesAntibody levelResearch and Analysis MethodsMicrobiologyAntibodies03 medical and health sciencesChronic hepatitisHepatitis - CClinical ResearchInternal medicineparasitic diseasesmedicineHumansImmunoassaysMolecular Biology TechniquesSensitivity analysesMolecular BiologyMedicine and health sciencesBiology and life sciencesFlavivirusesbusiness.industryDecision Treeslcsh:RHepatitis C antibodyOrganismsViral pathogensProteinsHepatitis C ChronicHepatitis C AntibodiesHepatitis virusesEconomic AnalysisMicrobial pathogensHealth CareEmerging Infectious DiseasesCost Effectiveness ResearchHealth Care FacilitiesImmunologyImmunologic Techniqueslcsh:QbusinessDigestive Diseases
researchProduct